Heart failure & cardiomyopathies
Characteristics, use of guideline–recommended medical therapies and clinical outcomes of patients with heart failure not enrolled in a quality registry: a comparison with the Swedish Heart Failure Registry
Authors' conclusion
Enrollment in the SwedeHF registry occurred in a minority of patients, and was associated with better adherence to guideline-recommended HF therapies and fewer major cardiovascular events and lower mortality.
Study context
- Population
- 90-day survivors after incident heart failure (HF) in Stockholm (2012–2021)
- Participants
- 48,374 incident HF cases
- Exposure
- Enrolled vs non-enrolled in SwedeHF registry
- Enrolledn = 4,878
- Outcome
- MACE (CV death, nonfatal MI or stroke), all-cause death and HF hospitalization
Methodological detailsregistry linkage
- Registry linkage
Main finding
As reported in the abstract
Enrolled vs Non-enrolledHazard ratio (95% CI)
Major CV event (CV death, nonfatal MI or stroke)
0.92(0.86–0.99)
All-cause death
0.87(0.82–0.92)
HF hospitalization
1.03(0.94–1.15)
Observational data: associations, not effects.
Further findings
Use of guideline-recommended HF therapies (initiation, persistence, adherence, dosage)
- Enrolled more likely to initiate, persist and adhere to, and achieve higher dosages
- P < 0.05 for all
Original publication
Characteristics, use of guideline–recommended medical therapies and clinical outcomes of patients with heart failure not enrolled in a quality registry: a comparison with the Swedish Heart Failure Registry. Eur Heart J Qual Care Clin Outcomes. Published 26 March 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →